{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:13:11Z","timestamp":1781561591807,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Two important virulence factors, urease and cagA, play an important role in <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) gastric cancer. Aim of this study was to investigate the expression level and function of <jats:italic>ureB<\/jats:italic> and <jats:italic>cagA<\/jats:italic> using small interfering RNAs (siRNA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>SS1 strain of <jats:italic>H. pylori<\/jats:italic> was considered as host for natural transformation. siRNA designed for <jats:italic>ureB<\/jats:italic> and <jats:italic>cagA<\/jats:italic> genes were inserted in pGPU6\/GFP\/Neo siRNA plasmid vector to evaluate using phenotypic and genotypic approaches. Then, qPCR was performed for determining inhibition rate of <jats:italic>ureB<\/jats:italic> and <jats:italic>cagA<\/jats:italic> gene expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression levels of siRNA-ureB and siRNA-cagA in the recombinant strain SS1 were reduced by about 5000 and 1000 fold, respectively, compared to the native <jats:italic>H. pylori<\/jats:italic> strain SS1. Also, preliminary evaluation of siRNA-ureB in vitro showed inhibition of urea enzyme activity. These data suggest that siRNA may be a powerful new tool for gene silencing in vitro, and for the development of RNAi-based anti-<jats:italic>H. pylori<\/jats:italic> therapies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results show that targeting <jats:italic>ureB<\/jats:italic> and <jats:italic>cagA<\/jats:italic> genes with siRNA seems to be a new strategy to inhibit urease enzyme activity, reduce inflammation and colonization rate.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-023-03143-x","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T07:02:19Z","timestamp":1702969339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reduction of UreB and CagA expression level by siRNA construct in Helicobacter pylori strain SS1"],"prefix":"10.1186","volume":"23","author":[{"given":"Hamid","family":"Motamedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Abiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhoushang","family":"Alvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"1","key":"3143_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41467-023-36218-4","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Zhao Y, Zhang H, Yang W, Yang J, Sun L, et al. Mechanism of regulation of the Helicobacter pylori Cag\u03b2 ATPase by CagZ. Nat Commun. 2023;14(1):479.","journal-title":"Nat Commun"},{"issue":"1","key":"3143_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou J-M, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"3143_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrc2857","volume":"10","author":"DB Polk","year":"2010","unstructured":"Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10(6):403\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3143_CR4","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609\u201316.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"3143_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/88563","volume":"8","author":"N-C Ha","year":"2001","unstructured":"Ha N-C, Oh S-T, Sung JY, Cha KA, Lee MH, Oh B-H. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol. 2001;8(6):505\u20139.","journal-title":"Nat Struct Biol"},{"issue":"7318","key":"3143_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/bmj.323.7318.920","volume":"323","author":"RP Logan","year":"2001","unstructured":"Logan RP, Walker MM. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ. 2001;323(7318):920.","journal-title":"BMJ."},{"key":"3143_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s10620-009-0928-8","volume":"55","author":"TL Fonseca","year":"2010","unstructured":"Fonseca TL, Moraes EP, Juliano CR, Silva AM, Scaini CJ, Mendoza-Sassi RA, et al. Detection of Helicobacter pylori by phenotypic and genotypic methods. Dig Dis Sci. 2010;55:1643\u20138.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3143_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0466-9","volume":"25","author":"W-L Chang","year":"2018","unstructured":"Chang W-L, Yeh Y-C, Sheu B-S. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018;25(1):1\u20139.","journal-title":"J Biomed Sci."},{"issue":"1","key":"3143_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","volume":"39","author":"C-Y Kao","year":"2016","unstructured":"Kao C-Y, Sheu B-S, Wu J-J. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomedical Journal. 2016;39(1):14\u201323.","journal-title":"Biomedical Journal"},{"key":"3143_CR10","doi-asserted-by":"publisher","unstructured":"Blaser MJ. Epidemiology and pathophysiology of Campylobacter pylori infections. Reviews of Infectious Diseases. 1990;12 Suppl 1:S99\u2013106. Epub 1990\/01\/01. https:\/\/doi.org\/10.1093\/clinids\/12.supplement_1.s99. PubMed PMID: 2406864.","DOI":"10.1093\/clinids\/12.supplement_1.s99"},{"key":"3143_CR11","doi-asserted-by":"publisher","unstructured":"Lucas B, Bumann D, Walduck A, Koesling J, Develioglu L, Meyer TF, et al. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)\/IL-13 receptor signaling. Infection and Immunity. 2001;69(3):1714\u201321. Epub 2001\/02\/17. https:\/\/doi.org\/10.1128\/iai.69.3.1714-1721.2001. PubMed PMID: 11179348; PubMed Central PMCID: PMCPMC98077.","DOI":"10.1128\/iai.69.3.1714-1721.2001"},{"issue":"1","key":"3143_CR12","doi-asserted-by":"publisher","first-page":"e0168944","DOI":"10.1371\/journal.pone.0168944","volume":"12","author":"J-T Zhou","year":"2017","unstructured":"Zhou J-T, Li C-L, Tan L-H, Xu Y-F, Liu Y-H, Mo Z-Z, et al. Inhibition of Helicobacter pylori and its associated urease by palmatine: investigation on the potential mechanism. PLoS ONE. 2017;12(1):e0168944.","journal-title":"PLoS ONE"},{"key":"3143_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jare.2018.05.003","volume":"13","author":"YF Rego","year":"2018","unstructured":"Rego YF, Queiroz MP, Brito TO, Carvalho PG, de Queiroz VT, de F\u00e1tima \u00c2, et al. A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria. J Adv Res. 2018;13:69\u2013100.","journal-title":"J Adv Res"},{"issue":"2","key":"3143_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pep.2009.07.016","volume":"69","author":"H Zhang","year":"2010","unstructured":"Zhang H, Liu M, Li Y, Zhao Y, He H, Yang G, et al. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori. Protein Expr Purif. 2010;69(2):127\u201331.","journal-title":"Protein Expr Purif"},{"issue":"25","key":"3143_CR15","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1073\/pnas.93.25.14648","volume":"93","author":"S Censini","year":"1996","unstructured":"Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci. 1996;93(25):14648\u201353.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3143_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/emboj\/cdg050","volume":"22","author":"M Selbach","year":"2003","unstructured":"Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 2003;22(3):515\u201328.","journal-title":"EMBO J"},{"key":"3143_CR17","doi-asserted-by":"publisher","unstructured":"Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clinical Microbiology Reviews. 2022;35(3):e0025821. Epub 2022\/04\/12. https:\/\/doi.org\/10.1128\/cmr.00258-21. PubMed PMID: 35404105; PubMed Central PMCID: PMCPMC9491184.","DOI":"10.1128\/cmr.00258-21"},{"issue":"1","key":"3143_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41598-018-37095-4","volume":"9","author":"M Abdullah","year":"2019","unstructured":"Abdullah M, Greenfield LK, Bronte-Tinkew D, Capurro MI, Rizzuti D, Jones NL. VacA promotes CagA accumulation in gastric epithelial cells during Helicobacter pylori infection. Sci Rep. 2019;9(1):38.","journal-title":"Sci Rep"},{"issue":"6","key":"3143_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/toxins8060173","volume":"8","author":"NJ Foegeding","year":"2016","unstructured":"Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An overview of Helicobacter pylori VacA toxin biology. Toxins. 2016;8(6):173.","journal-title":"Toxins"},{"issue":"3","key":"3143_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2014.02.008","volume":"15","author":"M Hatakeyama","year":"2014","unstructured":"Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306\u201316.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"3143_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cgh.2011.12.036","volume":"10","author":"B Sch\u00f6ttker","year":"2012","unstructured":"Sch\u00f6ttker B, Adamu MA, Weck MN, Brenner H. Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol. 2012;10(5):487-93.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"3143_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.micinf.2011.12.003","volume":"14","author":"K Kikuchi","year":"2012","unstructured":"Kikuchi K, Murata-Kamiya N, Kondo S, Hatakeyama M. Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling. Microbes Infect. 2012;14(5):470\u20136.","journal-title":"Microbes Infect"},{"key":"3143_CR23","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s10620-010-1512-y","volume":"56","author":"W Boonyanugomol","year":"2011","unstructured":"Boonyanugomol W, Chomvarin C, Baik S-C, Song J-Y, Hahnvajanawong C, Kim K-M, et al. Role of cag A-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells. Dig Dis Sci. 2011;56:1682\u201392.","journal-title":"Dig Dis Sci"},{"key":"3143_CR24","doi-asserted-by":"publisher","unstructured":"Sharma SA, Tummuru MK, Miller GG, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infection and Immunity. 1995;63(5):1681\u201387. Epub 1995\/05\/01. https:\/\/doi.org\/10.1128\/iai.63.5.1681-1687.1995. PubMed PMID: 7729872; PubMed Central PMCID: PMCPMC173210.","DOI":"10.1128\/iai.63.5.1681-1687.1995"},{"issue":"6669","key":"3143_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806\u201311.","journal-title":"Nature"},{"issue":"11","key":"3143_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tibtech.2010.07.009","volume":"28","author":"MR Lares","year":"2010","unstructured":"Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol. 2010;28(11):570\u20139.","journal-title":"Trends Biotechnol"},{"issue":"1","key":"3143_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jac\/dki416","volume":"57","author":"K Yanagihara","year":"2006","unstructured":"Yanagihara K, Tashiro M, Fukuda Y, Ohno H, Higashiyama Y, Miyazaki Y, et al. Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemother. 2006;57(1):122\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3143_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","volume":"36","author":"M Friedrich","year":"2022","unstructured":"Friedrich M, Aigner A. Therapeutic siRNA: state-of-the-art and future perspectives. BioDrugs. 2022;36(5):549\u201371.","journal-title":"BioDrugs"},{"key":"3143_CR29","doi-asserted-by":"crossref","unstructured":"Naito Y, Yoshimura J, Morishita S, Ui-Tei K. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinformatics. 2009;10(1):1\u20138.","DOI":"10.1186\/1471-2105-10-392"},{"issue":"3","key":"3143_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000337","volume":"5","author":"EA Lin","year":"2009","unstructured":"Lin EA, Zhang X-S, Levine SM, Gill SR, Falush D, Blaser MJ. Natural transformation of Helicobacter pylori involves the integration of short DNA fragments interrupted by gaps of variable size. PLoS Pathog. 2009;5(3): e1000337.","journal-title":"PLoS Pathog"},{"issue":"1","key":"3143_CR31","first-page":"60","volume":"2","author":"T Hall","year":"2011","unstructured":"Hall T, Biosciences I, Carlsbad C. BioEdit: an important software for molecular biology. GERF Bull Biosci. 2011;2(1):60\u20131.","journal-title":"GERF Bull Biosci"},{"key":"3143_CR32","doi-asserted-by":"crossref","unstructured":"Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST\u00a9) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30(9):e36-e.","DOI":"10.1093\/nar\/30.9.e36"},{"issue":"13","key":"3143_CR33","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1096\/fj.07-8501com","volume":"21","author":"SM Levine","year":"2007","unstructured":"Levine SM, Lin EA, Emara W, Kang J, DiBenedetto M, Ando T, et al. Plastic cells and populations: DNA substrate characteristics in Helicobacter pylori transformation define a flexible but conservative system for genomic variation. FASEB J. 2007;21(13):3458\u201367.","journal-title":"FASEB J"},{"issue":"2","key":"3143_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1574-6968.2000.tb09117.x","volume":"186","author":"DA Israel","year":"2000","unstructured":"Israel DA, Lou AS, Blaser MJ. Characteristics of Helicobacter pylori natural transformation. FEMS Microbiol Lett. 2000;186(2):275\u201380.","journal-title":"FEMS Microbiol Lett"},{"issue":"8","key":"3143_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2174\/138920312804871094","volume":"13","author":"I Konieczna","year":"2012","unstructured":"Konieczna I, Zarnowiec P, Kwinkowski M, Kolesinska B, Fraczyk J, Kaminski Z, et al. Bacterial urease and its role in long-lasting human diseases. Curr Protein Pept Sci. 2012;13(8):789\u2013806.","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"3143_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jcp.2009.072595","volume":"63","author":"C Follmer","year":"2010","unstructured":"Follmer C. Ureases as a target for the treatment of gastric and urinary infections. J Clin Pathol. 2010;63(5):424\u201330.","journal-title":"J Clin Pathol"},{"issue":"1","key":"3143_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jare.2014.09.001","volume":"6","author":"LV Modolo","year":"2015","unstructured":"Modolo LV, de Souza AX, Horta LP, Araujo DP, de F\u00e1tima \u00c2. An overview on the potential of natural products as ureases inhibitors: A review. J Adv Res. 2015;6(1):35\u201344.","journal-title":"J Adv Res"},{"key":"3143_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1018884322973","volume":"43","author":"AJ Pope","year":"1998","unstructured":"Pope AJ, Toseland N, Rushant B, Richardson S, Mcvey M, Hills J. Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro. Digest Dis Sci. 1998;43:109\u201319.","journal-title":"Digest Dis Sci."},{"key":"3143_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5487\/TR.2014.30.1.045","volume":"30","author":"J Jung","year":"2014","unstructured":"Jung J, Choi JS, Jeong C-S. Inhibitory activities of palmatine from coptis chinensis against helicobactor pylori and gastric damage. Toxicol Res. 2014;30:45\u20138.","journal-title":"Toxicol Res"},{"issue":"8","key":"3143_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182437","volume":"12","author":"K Macegoniuk","year":"2017","unstructured":"Macegoniuk K, Grela E, Biernat M, Psurski M, Go\u015bciniak G, Dzie\u0142ak A, et al. Aminophosphinates against Helicobacter pylori ureolysis\u2014Biochemical and whole-cell inhibition characteristics. PLoS ONE. 2017;12(8): e0182437.","journal-title":"PLoS ONE"},{"key":"3143_CR41","doi-asserted-by":"crossref","unstructured":"Jain SK, Haider T, Kumar A, Jain A. Lectin-conjugated clarithromycin and acetohydroxamic acid-loaded PLGA nanoparticles: A novel approach for effective treatment of H. pylori. AAPS PharmSciTech. 2016;17:1131\u201340.","DOI":"10.1208\/s12249-015-0443-5"},{"issue":"1","key":"3143_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/children4010002","volume":"4","author":"ST Hassan","year":"2017","unstructured":"Hassan ST, \u0160udomov\u00e1 M. The development of urease inhibitors: what opportunities exist for better treatment of Helicobacter pylori infection in children? Children. 2017;4(1):2.","journal-title":"Children"},{"issue":"1","key":"3143_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41419-017-0020-9","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X, et al. NF-\u03baB\/miR-223-3p\/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression. Cell Death Dis. 2018;9(1):12.","journal-title":"Cell Death Dis"},{"issue":"78","key":"3143_CR44","first-page":"1868","volume":"54","author":"Y Yan","year":"2007","unstructured":"Yan Y, Zhan W, Zhao G, Ma J, Cai S. Use of SiRNA to investigate the role of CagA on H. pylori induced IL-8 production from gastric epithelial cells. Hepato Gastroenterol. 2007;54(78):1868\u201373.","journal-title":"Hepato Gastroenterol."},{"key":"3143_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fcimb.2017.00417","volume":"7","author":"N Li","year":"2017","unstructured":"Li N, Tang B, Jia Y-p, Zhu P, Zhuang Y, Fang Y, et al. Helicobacter pylori CagA protein negatively regulates autophagy and promotes inflammatory response via c-Met-PI3K\/Akt-mTOR signaling pathway. Front Cell Infect Microbiol. 2017;7:417.","journal-title":"Front Cell Infect Microbiol."},{"key":"3143_CR46","doi-asserted-by":"crossref","unstructured":"Lee KS, Kalantzis A, Jackson CB, O\u2019Connor L, Murata-Kamiya N, Hatakeyama M, et al. Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3\u03b3 via gastric STAT3 activation. PLoS ONE. 2012;7(2):e30786.","DOI":"10.1371\/journal.pone.0030786"},{"issue":"2","key":"3143_CR47","doi-asserted-by":"publisher","first-page":"e17510","DOI":"10.1371\/journal.pone.0017510","volume":"6","author":"DP Barry","year":"2011","unstructured":"Barry DP, Asim M, Leiman DA, de Sablet T, Singh K, Casero RA Jr, et al. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS ONE. 2011;6(2):e17510.","journal-title":"PLoS ONE"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-03143-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-03143-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-03143-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T18:03:38Z","timestamp":1703009018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-03143-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3143"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-03143-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out with the Code of Ethics Committee (Ref. ID: IR. KUMS. AEC.1401.022) adopted by Kermanshah University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}